Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Everest Medicines Announces Strategic Partnership with Shanghai Pharma Subsidiary
Everest Medicines, a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines […]
Taros Chemicals and Welab Barcelona Announce Partnership to Provide Integrated Drug Discovery Services
Taros Chemicals, a leading German contract research (CRO) player in small molecules, and Welab Barcelona, […]
AmerisourceBergen Kicks Off Strategic Relationship with Civica
Starting today, global healthcare company AmerisourceBergen will serve as an exclusive distribution partner and provide […]
Amneal Announces Strategic European Partnership with Orion Corporation
Amneal Pharmaceuticals, has announced it has signed a long-term license agreement with Orion Corporation to […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more